MedPath

Short-term weight loss and body composition changes in patients with obesity by GLP-1 and GIP/GLP-1 receptor agonists in combination with low-calorie diet.

Not Applicable
Conditions
obesity
Registration Number
JPRN-UMIN000053234
Lead Sponsor
Kimitsu Chuo Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
40
Inclusion Criteria

Not provided

Exclusion Criteria

(1) Patients who were or plan to be pregnant. (2) Patients who were unable to cooperate with treatment due to mental illness or language barrier. (3) Patients with a history of GLP-1 receptor agonist use other than oral and subcutaneous semaglutide and tirzepatide. (4) Patients who failed to continue GLP-1 or GIP/GLP-1 receptor agonists during hospitalization. (5) Patients who were unable to continue the LCD provided by our hospital. (6) Other patients deemed inappropriate as research subjects by the principal investigator.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath